Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Medical Therapy in Patients with Moderate to Severe, Steroid-Resistant, Thyroid Eye Disease

Published:2023-10-01 Issue:10 Volume:33 Page:1237-1244
ISSN:1050-7256
Container-title:Thyroid®
language:en
Short-container-title:Thyroid®

Author:

Toro-Tobon David¹^ORCID,Rachmasari Kharisa N.¹,Bradley Elizabeth A.²,Wagner Lilly H.²,Tooley Andrea A.²,Stokken Janalee K.³,Stan Marius N.¹^ORCID

Affiliation:

1. Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota, USA.

2. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, USA.

3. Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota, USA.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2023.0167

Reference28 articles.

1. Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review

2. Graves' Ophthalmopathy

3. Thyroid Eye Disease: Navigating the New Treatment Landscape

4. Spontaneous Improvement of Untreated Mild Graves' Ophthalmopathy: Rundle's Curve Revisited

5. Methylprednisolone and Graves' ophthalmopathy.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid Eye Disease: Advancements in Orbital and Ocular Pathology Management;Journal of Personalized Medicine;2024-07-22

2. Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease;Endocrine Practice;2024-06

3. Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study;International Ophthalmology;2024-04-16

4. Real-World Use of Teprotumumab and Tocilizumab in Moderate-to-Severe Steroid-Resistant Thyroid Eye Disease;Clinical Thyroidology®;2023-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3